The Top 10 Generics Companies Strategic
insight, growth opportunities and competitive dynamics in the US and Europe
"Identify upcoming patent expiries and discover opportunities to maximize your
revenue streams with the help of our new management report …"
Understand
the future of the generics market and identify the successful strategies
undertaken by the industry’s giants with Business Insights new report 'The
Top 10 Generics Companies: Strategic insight, growth opportunities and
competitive dynamics in the
US and
Europe'.
'The Top 10 Generics Companies'
is a new
management report which utilizes gold standard IMS data to analyze the
marketed portfolios of the top 10 generics players including Sandoz,
Teva, Mylan and Ratiopharm.
For each company this report examines geographic and therapeutic focus, sales
growth of key products, proportion of generic and branded sales, as well as
recent M&A and licensing activity.
Use this latest report to benchmark your company’s generics strategy
against those of the leading players, and understand how recent major
consolidation activity has impacted the generics marketplace.
This report will enable you to...
-
Discover
future top selling products
by examining upcoming patent expiries and recent first to file generic
approvals, ensuring that you can rapidly identify opportunities to maximize
your revenue streams.
-
Anticipate
future threats to the market,
by analyzing key current trends outlined in this report and ensure that you
are able to respond effectively to changes in the market.
-
Identify
which companies have gained first to file patent approvals
and utilize advanced drug delivery technology, ensuring that you fully
exploit these tactics to gain a competitive edge.
Report information:
>
Price:
$2,875
>
Published:
March- 06
> Format:
PDF
To purchase click the title:
The Top 10 Generics Companies Strategic insight, growth opportunities and
competitive dynamics in the US and Europe
